Flynn James E Picked Mannkind Corp (NASDAQ:MNKD) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Mannkind Corp (NASDAQ:MNKD) reported that Flynn James E has picked up 5,217,391 of common stock as of 2017-04-19.

The acquisition brings the aggregate amount owned by Flynn James E to a total of 5,217,391 representing a 5.17% stake in the company.

For those not familiar with the company, MannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company’s fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

A glance at Mannkind Corp (NASDAQ:MNKD)’s key stats reveals a current market capitalization of 113.14 Million based on 95.78 Million shares outstanding and a price at last close of $1.22 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-01-03, Pfeffer picked up 4,540 at a purchase price of $0.54. This brings their total holding to 403,085 as of the date of the filing.

On the sell side, the most recent transaction saw Alinaya unload 6,294 shares at a sale price of $1.06. This brings their total holding to 131,413.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Mannkind Corp (NASDAQ:MNKD) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Guess Who Picked Nexvet Biopharma Plc. (NASDAQ:NVET) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Nexvet Biopharma Plc. (NASDAQ:NVET) reported that Farallon Capital has picked up 1,046,345 of common stock as of 2017-04-19.

The acquisition brings the aggregate amount owned by Farallon Capital to a total of 1,046,345 representing a 8.7% stake in the company.

For those not familiar with the company, Nexvet Biopharma public limited company is a clinical-stage biopharmaceutical company focused on transforming the therapeutic market for companion animals by developing and commercializing species-specific biologics. The Company’s platform technology, which it refers to as PETization, is an algorithmic approach that enables the Company to create monoclonal antibodies (mAbs) a type of biologic, that are designed to be recognized as self or native by an animal’s immune system, a property referred to as 100% species-specificity. PETization is designed to build upon the safety and efficacy data from clinically tested human therapies to create new therapies for companion animals. Biologics generally include mAbs, which are targeted antibodies derived from identical (clonal) cells. The Company’s advanced product candidates are in pivotal-phase development: ranevetmab (or NV-01) and frunevetmab (or NV-02).

A glance at Nexvet Biopharma Plc. (NASDAQ:NVET)’s key stats reveals a current market capitalization of 77.57 Million based on 11.75 Million shares outstanding and a price at last close of $6.61 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2016-03-04, Gearing picked up 9,000 at a purchase price of $3.35. This brings their total holding to 125,903 as of the date of the filing.

On the sell side, the most recent transaction saw Farrell unload 132 shares at a sale price of $3.27. This brings their total holding to 0.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Nexvet Biopharma Plc. (NASDAQ:NVET) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Here’s Who Just Picked Up Musclepharm Corp (OTCMKTS:MSLP) Shares

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Musclepharm Corp (OTCMKTS:MSLP) reported that Amerop Holdings, Inc. has picked up 2,136,781 of common stock as of 2017-04-19.

The acquisition brings the aggregate amount owned by Amerop Holdings, Inc. to a total of 2,136,781 representing a 15.15% stake in the company.

For those not familiar with the company, MusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company’s portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman’s lifestyle utilizing ingredients that cover the range of busy women’s needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.

A glance at Musclepharm Corp (OTCMKTS:MSLP)’s key stats reveals a current market capitalization of 30.34 Million based on 14.11 Million shares outstanding and a price at last close of $2.15 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2017-04-10, Amerop picked up 14,000 at a purchase price of $2.15. This brings their total holding to 2,136,781 as of the date of the filing.

On the sell side, the most recent transaction saw Bluher unload 3,000 shares at a sale price of $9.10. This brings their total holding to 190,118.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Musclepharm Corp (OTCMKTS:MSLP) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

See Who Just Entertainment Gaming Asia Inc. (NASDAQ:EGT) Shares

egt

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entertainment Gaming Asia Inc. (NASDAQ:EGT) reported that Melco International Development Ltd. has picked up 9,378,074 of common stock as of 2017-04-18.

The acquisition brings the aggregate amount owned by Melco International Development Ltd. to a total of 9,378,074 representing a 64.8% stake in the company.

For those not familiar with the company, Entertainment Gaming Asia Inc. is a gaming company. The Company is engaged in slot operations, which include the ownership and leasing of electronic gaming machines (EGMs) in resorts, hotels and other venues; the design, manufacture and distribution of gaming chips and plaques, and the development of a social casino gaming platform designed for the Pan-Asian market. The Company conducts business in two operating segments: gaming operations, which includes slot participation operations, and gaming products, which consists of the design, manufacture and distribution of gaming chips and plaques. Its gaming operations consist of slot operations in Cambodia and the Philippines. Its gaming products consist of the manufacture and sale of gaming chips and plaques under its Dolphin brand and the distribution of gaming products in select markets for third-party suppliers. It identifies and develops new gaming venues, acquires EGMs, casino management systems and other gaming peripherals.

A glance at Entertainment Gaming Asia Inc. (NASDAQ:EGT)’s key stats reveals a current market capitalization of 22.47 Million based on 14.46 Million shares outstanding and a price at last close of $1.65 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2013-08-22, Divito picked up 500 at a purchase price of $1.34. This brings their total holding to 46,500 as of the date of the filing.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entertainment Gaming Asia Inc. (NASDAQ:EGT) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Agritech Worldwide Inc. (OTCMKTS:FBER) is Attracting Smart Money

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Agritech Worldwide Inc. (OTCMKTS:FBER) reported that Kahn Jonathan Efrem has picked up 10,320,889 of common stock as of 2017-04-18.

The acquisition brings the aggregate amount owned by Kahn Jonathan Efrem to a total of 10,320,889 representing a 6.6% stake in the company.

For those not familiar with the company, Agritech Worldwide, Inc., formerly Z Trim Holdings, Inc., is an agricultural technology company. The Company owns existing, and seeks to develop new, products and processes that convert generally available agricultural by-products into multi-functional all-natural ingredients that can be used in food manufacturing and other industries. Its products cater to food and nutritional beverage industry, including fat-free, low-fat, reduced-fat and full-fat, across meats, baked goods, dairy and non-dairy products, snacks, beverages, dressings, sauces and dips. Its industrial products division focuses on the manufacture, marketing and sales of products designed specifically for industrial applications, including oil drilling fluids, petroleum coke, charcoal briquettes, hydraulic fracturing, and paper and wood adhesives. Its product portfolio of multifunctional food ingredients includes Corn Z Trim (both genetically modified organism (GMO) and non-GMO) and Oat Z-Trim.

A glance at Agritech Worldwide Inc. (OTCMKTS:FBER)’s key stats reveals a current market capitalization of 1.80 Million based on 154.98 Million shares outstanding and a price at last close of $0.00850 per share.

Looking at insider activity, there are a few transactions worth noting.

Specifically, on 2013-11-29, Garfinkle picked up 30,000 at a purchase price of $0.60. This brings their total holding to 777,448 as of the date of the filing.

On the sell side, the most recent transaction saw Kahn unload 400,000 shares at a sale price of $0.01. This brings their total holding to 7,383,663.

It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Agritech Worldwide Inc. (OTCMKTS:FBER) as things move forward to see if its progress aligns with these transactions.

Subscribe below and we’ll keep you on top of what’s happening before it moves markets.

 

 

 

Skip to content